Home > Insider Trading > Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Aegerion Pharmaceuticals, Inc. (AEGR), Rigel Pharmaceuticals, Inc. (RIGL), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The Rise of Little Pharma

Big Pharma gets plenty of hype. But is Little Pharma where investors can make the biggest gains? The answer to that question is a resounding "yes." Those larger gains, though, come with more risks.

Keep Reading →

September 17th, 2013 - News

Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?

To the average investor, there are many methods market participants can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading activity.

Keep Reading →

September 17th, 2013 - News

Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)

In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.

Keep Reading →

September 17th, 2013 - News

What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)

To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund and insider trading activity.

Keep Reading →

September 13th, 2013 - News

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.

Keep Reading →

September 4th, 2013 - News

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies. A couple of the most under-the-radar are hedge fund and insider trading interest.

Keep Reading →

September 3rd, 2013 - News

Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech

With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

September 1st, 2013 - News

Hedge Funds Aren't Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore

In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.

Keep Reading →

August 30th, 2013 - News

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading interest.

Keep Reading →

August 26th, 2013 - News